{"nct_id":"NCT04177823","title":"A Study of Belantamab Mafodotin to Investigate Safety, Tolerability, Pharmacokinetics, Immunogenicity and Clinical Activity in Participants With Relapsed/Refractory Multiple Myeloma (RRMM)","status":"COMPLETED","status_verified_date":"2025-02","start_date":"2019-12-09","start_date_type":"ACTUAL","primary_completion_date":"2021-12-30","primary_completion_date_type":"ACTUAL","completion_date":"2021-12-30","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GSK"]}